Evommune, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
1841 PAGE MILL RD, PALO ALTO, CA, 94304
Mailing Address
1841 PAGE MILL RD, PALO ALTO, CA, 94304
Phone
(650) 223-7745
Fiscal Year End
1231
EIN
850742575
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 5, 2026 | View on SEC |
| 10-K Annual financial report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 10, 2026 | View on SEC |
IPO Filings
S-1
October 9, 2025
- Targeting a $90 billion market for chronic inflammation diseases with two mid-stage drugs (EVO756 and EVO301) aiming to address root causes.
- Experienced leadership team with prior FDA approval success and board members involved in successful IPOs.
Annual Reports
10-K
March 5, 2026
- Successfully completed its Initial Public Offering (IPO) in November 2025, raising $157.3 million and listing on the NYSE.
- Significantly strengthened financial position with $220.8 million raised from financing activities, resulting in a cash runway of approximately 34 months.
Insider Trading
BUY
1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN
Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB
Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA
Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN
Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.